Neurocrine Biosciences
NBIX
#1309
Rank
A$21.91 B
Marketcap
$216.41
Share price
2.74%
Change (1 day)
20.89%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company